Medications

blinatumomab

Bispecific Antibodies

Approved use in

Acute Lymphoblastic Leukemia

Calaspargase pegol

Enzyme-Based Chemotherapy

Approved use in

Acute Lymphoblastic Leukemia

Clofarabine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

cytarabine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

dasatinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Lymphoblastic Leukemia

daunorubicin

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

dexamethasone

Systemic Steroids

Approved use in

Acute Lymphoblastic Leukemia

doxorubicin

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

imatinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Lymphoblastic Leukemia

inotuzumab ozogamicin

Antibody-Drug Conjugates

Approved use in

Acute Lymphoblastic Leukemia

mercaptopurine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

methotrexate

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

nelarabine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

Obecabtagene autoleucel

CAR T-Cell Therapy

Approved use in

Acute Lymphoblastic Leukemia

pegaspargase

Enzyme-Based Chemotherapy

Approved use in

Acute Lymphoblastic Leukemia

ponatinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Lymphoblastic Leukemia

rituximab

Monoclonal Antibodies

Approved use in

Acute Lymphoblastic Leukemia

tisagenlecleucel

CAR T-Cell Therapy

Approved use in

Acute Lymphoblastic Leukemia